-
Product Insights
Aspergillosis Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Aspergillosis Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Aspergillosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Aspergillosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs...
-
Product Insights
Bacterial Pneumonia Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Bacterial Pneumonia Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Bacterial Pneumonia Clinical trials scenario. This report provides top line data relating to the clinical trials on Bacterial Pneumonia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also...
-
Product Insights
Diphtheria Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Diphtheria Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Diphtheria Clinical trials scenario. This report provides top line data relating to the clinical trials on Diphtheria. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs...
-
Product Insights
Fungal Infections Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Fungal Infections Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Fungal Infections Clinical trials scenario. This report provides top line data relating to the clinical trials on Fungal Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also...
-
Sector Analysis
Clostridium Difficile - Competitive Landscape in 2021
The Clostridium difficile infections (CDI) pipeline consists of 100 drugs, C. difficile toxin A and deoxyribonucleic acid (DNA) synthesis inhibition emerge as key targets. Big Pharma companies dominates R&D in this indication. Antibiotics will be the predominant product class in the C. difficile infection market. However, emonstrating cost-effectiveness of novel interventions versus metronidazole and vancomycin would be challenging.
-
Product Insights
Coronavirus Disease 2019 (COVID-19) Global Clinical Trials Review, H1, 2020
GlobalData's clinical trial report, “Coronavirus Disease 2019 (COVID-19) Global Clinical Trials Review, H1, 2020" provides an overview of Coronavirus Disease 2019 (COVID-19) Clinical trials scenario. This report provides top line data relating to the clinical trials on Coronavirus Disease 2019 (COVID-19). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Helicobacter Pylori Infections Disease - Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Helicobacter pylori Infections Global Clinical Trials Review, H1, 2020" provides an overview of Helicobacter pylori Infections Clinical trials scenario. This report provides top line data relating to the clinical trials on Helicobacter pylori Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Vulvovaginal Candidiasis Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Vulvovaginal Candidiasis Global Clinical Trials Review, H2, 2018" provides an overview of Vulvovaginal Candidiasis clinical trials scenario. This report provides top line data relating to the clinical trials on Vulvovaginal Candidiasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Warts Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Warts Global Clinical Trials Review, H2, 2018" provides an overview of Warts clinical trials scenario. This report provides top line data relating to the clinical trials on Warts. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
West Nile Virus Infections Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “West Nile Virus Infections Global Clinical Trials Review, H2, 2018" provides an overview of West Nile Virus Infections clinical trials scenario. This report provides top line data relating to the clinical trials on West Nile Virus Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...